Gene 'switches off' ovarian cancer

Gene 'switches off' ovarian cancer

Cancer scientists believe they have found a gene which - when working properly - may have the ability to stop ovarian cancer developing. Scientists at Cancer Research UK's Edinburgh oncology unit fo... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4180

Professor Thomas R. DeGregori visits capital

“If technology is killing us, why are we living longer?” This and other pertinent questions were put to an invited audience at the American Embassy in Wellington today by Tomas R. DeGregori, Econo... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4179

ERMA seeking information from PPL

Newsroom reports that the Environmental Risk Management Authority wants some immediate answers from the biotechnology company, PPL Therapeutics, about the fate of transgenic sheep in Southern Waikato.... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4178

GM food myths, misconceptions and misinformation..

On June 15, a group of anti-biotech organic food activists calling themselves the "Independent Science Panel" issued a report called The Case for a GM-Free Sustainable World, regarding crops and foods... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4177

Talks collapse on efforts to open Europe to GM

New York Times writer David Leonhardt says talks between the United States and the European Union over opening up Europe to genetically modified foods broke down in Geneva today, heightening trans-Atl... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4174

World's biotech leaders invited 'Down Under'

Queensland Premier Peter Beattie is inviting delegates to the world's biggest biotech event which begins in Washington DC tomorrow to come Down Under for some of the industry's largest conferences.... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4173

Future dicey for GE sheep flock

The New Zealand Herald reports that Scottish biotechnology company PPL Therapeutics is pulling the plug for at least three years on New Zealand's first transgenic livestock field trial, which involves... More... http://www.lifesciencesnetwork.com/news-detail.asp?newsID=4172

© Scoop Media